1. Bãrbuş E, Peştean C, Larg MI, Piciu D. Quality of life in thyroid cancer patients: a literature review. Clujul Med. 2017;90(2):147–53.
2. European Network of Cancer Registries (ENCR) . Thyroid Cancer Factsheet. Online Document. 2017. https://www.encr.eu/sites/default/files/factsheets/ENCR_Factsheet_Thyroid_2017.pdf. Accessed 20 Dec 2018.
3. Karapanou O, Papadopoulos A, Vlassopoulou B, et al. Health status of Greek thyroid cancer patients after radioiodine administration compared to a demographically matched general population sample. Hell J Nucl Med. 2012;15(2):98–102.
4. Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer. Cancer. 2013;119(2):259–65.
5. Andresen NS, Buatti JM, Tewfik HH, Pagedar NA, Anderson CM, Watkins JM. Radioiodine ablation following thyroidectomy for differentiated thyroid cancer: literature review of utility, dose, and toxicity. Eur Thyroid J. 2017;6(4):187–96.